Successful enucleation of a fluorine-18-fluorodeoxyglucose positron emission tomography positive esophageal leiomyoma in the prone position using sponge spacer and intra-esophageal balloon compression

Gen Thorac Cardiovasc Surg. 2012 Aug;60(8):542-5. doi: 10.1007/s11748-012-0027-1. Epub 2012 May 8.

Abstract

Recently, prone position esophagectomy for esophageal cancer is thought to be an easier and safer procedure. Here, we introduced prone position for enucleation of the fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET) positive esophageal leiomyoma. The patient was a 47-year-old man with a 4 cm mid-thoracic esophageal submucosal tumor. The tumor was enucleated safely without injury of the esophageal mucosa under the gravity effect of the prone position with use of a sponge spacer and Sengstaken-Blakemore balloon. Postoperative examination revealed that the tumor was a leiomyoma that was positive for smooth muscle actin and negative for CD117. Postoperative course was uneventful and the patient was discharged on day 7 after the operation. The prone position with use of a sponge spacer and Sengstaken-Blakemore balloon was a safer and easier procedure for the enucleation of the esophageal submucosal tumor.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers, Tumor / analysis
  • Biopsy
  • Dilatation / instrumentation
  • Esophageal Neoplasms / chemistry
  • Esophageal Neoplasms / diagnostic imaging*
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / surgery*
  • Esophagectomy / instrumentation
  • Esophagectomy / methods*
  • Fluorodeoxyglucose F18*
  • Humans
  • Leiomyoma / chemistry
  • Leiomyoma / diagnostic imaging*
  • Leiomyoma / pathology
  • Leiomyoma / surgery*
  • Male
  • Middle Aged
  • Multimodal Imaging*
  • Patient Positioning*
  • Positron-Emission Tomography*
  • Predictive Value of Tests
  • Prone Position*
  • Radiopharmaceuticals*
  • Surgical Sponges
  • Thoracoscopy
  • Tomography, X-Ray Computed*
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18